Authors:
Nienaber, VL
Davidson, D
Edalji, R
Giranda, VL
Klinghofer, V
Henkin, J
Magdalinos, P
Mantei, R
Merrick, S
Severin, JM
Smith, RA
Stewart, K
Walter, K
Wang, JY
Wendt, M
Weitzberg, M
Zhao, XM
Rockway, T
Citation: Vl. Nienaber et al., Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite, STRUCT F D, 8(5), 2000, pp. 553-563
Citation: Jy. Wang et al., Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases, J CELL BIOC, 77(3), 2000, pp. 465-473
Authors:
Nienaber, V
Wang, JY
Davidson, D
Henkin, J
Citation: V. Nienaber et al., Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite, J BIOL CHEM, 275(10), 2000, pp. 7239-7248
Authors:
Schlesinger, Z
Vered, Z
Friedenson, A
Reisin, L
Jafari, J
Flieb, T
Sclarovsky, S
Friedman, Y
Ostfeld, B
Solodky, A
Abinader, E
Rochfleish, S
Palant, A
Schneider, H
Rosenfeld, T
Khalid, S
Wolfson, E
Kishon, Y
Narinsky, R
Rotzak, R
Davidov, A
Levine, G
Zahavi, I
Vitrai, J
Diker, D
Pelled, B
Pardu, J
Galamidi, J
Majadla, R
Laniado, S
Sherf, L
Braun, S
Eschar, Y
Caspi, A
Arditi, A
Botwin, S
Arkavi, L
Ziv, M
David, D
Weisenberg, D
Kohanovski, M
Meisel, S
Rougin, N
Yahalom, M
Glusman-Vazan, A
Markiewitz, W
Motlak, D
Lessick, J
Kagan, G
Marmour, A
Flich, M
Solomon, R
Tzivoni, D
Zion, M
Balkin, J
Rabinowitz, B
Barasch, E
Brill, Z
Aharon, L
Asman, A
Battler, A
Gueron, M
Cristal, N
Liel, N
Tsatskis, B
Henkin, J
Citation: Z. Schlesinger et al., Secondary prevention by raising HDL cholesterol and reducing triglyceridesin patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study, CIRCULATION, 102(1), 2000, pp. 21-27
Authors:
Dawson, DW
Volpert, OV
Pearce, SFA
Schneider, AJ
Silverstein, RL
Henkin, J
Bouck, NP
Citation: Dw. Dawson et al., Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat, MOLEC PHARM, 55(2), 1999, pp. 332-338